| Drug Name: | Co-careldopa |
|---|
| Drug Class: | Antiparkinsonian agent |
|---|
| Mechanism of Action: | - Levodopa is converted to dopamine in the brain, which helps to improve motor function in Parkinson's disease
- Carbidopa inhibits the breakdown of levodopa in the bloodstream, allowing more levodopa to reach the brain
|
|---|
| Use: | - Treatment of Parkinson's disease
- Relief of symptoms such as tremors, stiffness, and slowness of movement
|
|---|
| Side Effects: | - Nausea and vomiting
- Dizziness
- Headache
- Insomnia
- Hallucinations
- Dyskinesia (involuntary movements)
|
|---|
| Contraindications: | - Hypersensitivity to levodopa or carbidopa
- Narrow-angle glaucoma
- History of melanoma
- Use of nonselective MAO inhibitors
|
|---|
| Specialty: | |
|---|